Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma

被引:0
|
作者
Wen-Kai Xia
Zhi-Li Liu
Dong Shen
Qing-Feng Lin
Jun Su
Wei-Dong Mao
机构
[1] The Affiliated Jiangyin Hospital of Southeast University Medical College,Department of Nephrology
[2] The Affiliated Jiangyin Hospital of Southeast University Medical College,Department of Oncology
关键词
Osteosarcoma; NLR; PLR; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Prognostic Role of Pre-Treatment Symptoms for Survival of Patients Irradiated for Brain Metastases
    Rades, Dirk
    Hansen, Heinke C.
    Dziggel, Liesa
    Janssen, Stefan
    Schild, Steven E.
    ANTICANCER RESEARCH, 2019, 39 (08) : 4273 - 4277
  • [32] Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients
    Szkandera, Joanna
    Gerger, Armin
    Liegl-Atzwanger, Bernadette
    Stotz, Michael
    Samonigg, Hellmut
    Ploner, Ferdinand
    Stojakovic, Tatjana
    Leithner, Andreas
    Pichler, Martin
    PLOS ONE, 2014, 9 (09):
  • [33] The prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio (NLR) in colorectal cancer: A systematic review and meta-analysis
    Naszai, Mate
    Kurjan, Alina
    Maughan, Timothy S.
    CANCER MEDICINE, 2021, 10 (17): : 5983 - 5997
  • [34] Prognostic Significance of Pre-treatment Neutrophil: Lymphocyte Ratio in Japanese Patients with Breast Cancer
    Nakano, Kiichiroh
    Hosoda, Mitsuchika
    Yamamoto, Mitsugu
    Yamashita, Hiroko
    ANTICANCER RESEARCH, 2014, 34 (07) : 3819 - 3824
  • [35] Prognostic impact of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in nasopharyngeal carcinoma: A retrospective study of 180 Taiwanese patients (vol 43, pg 463, 2018)
    Liao, L. -J.
    Hsu, W. -L.
    Wang, C. -T.
    Lo, W. -C.
    Cheng, P. -W.
    Shueng, P. -W.
    Hsieh, C. -H.
    Chiu, Y. -L.
    Lin, Y. -C.
    CLINICAL OTOLARYNGOLOGY, 2018, 43 (06) : 1644 - 1644
  • [36] NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF
    Duzenli, Tolga
    Koseoglu, Huseyin
    Akyol, Taner
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (09) : E103 - E103
  • [37] Pre-Treatment Performance Status and Stage at Diagnosis in Patients with Head and Neck Cancers
    Krishnatreya, Manigreeva
    Rahman, Tashnin
    Kataki, Amal Chandra
    Sharma, Jagannath Dev
    Nandy, Pintu
    Baishya, Nizara
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (19) : 8479 - 8482
  • [38] Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy
    Rajwa, P.
    Zyczkowski, M.
    Paradysz, A.
    Bujak, K.
    Bryniarski, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (10) : 3027 - 3037
  • [39] Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study.
    Shulman, David Stephen
    Klega, Kelly S.
    Chen, Nan
    Gohn, Elliot
    Henry, Donovan
    Choy, Edwin
    Cash, Thomas
    Schultz, Kris Ann Pinekenstein
    Mascarenhas, Leo
    Bagatell, Rochelle
    Turpin, Brian
    Setty, Bhuvana
    DeNardo, Bradley
    Hawkins, Douglas S.
    Bishop, Michael W.
    Shah, Avanthi T.
    Maese, Luke Devon
    London, Wendy B.
    DuBois, Steven G.
    Crompton, Brian D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Prognostic significance of pre-treatment levels of vascular endothelial growth factor in patients with oesophageal carcinoma
    Grannell, MS
    McDonnell, CO
    Harmey, J
    Bouchier-Hayes, DJ
    Walsh, TN
    BRITISH JOURNAL OF SURGERY, 2003, 90 (05) : 635 - 636